Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.31
+0.36 (2.58%)
At close: Mar 16, 2026, 4:00 PM EDT
14.10
-0.21 (-1.47%)
After-hours: Mar 16, 2026, 7:50 PM EDT
Company Description
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis.
It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases.
The company was founded in 1993 and is headquartered in Edmonton, Canada.
Aurinia Pharmaceuticals Inc.
| Country | Canada |
| Founded | 1993 |
| IPO Date | Jan 26, 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 128 |
| CEO | Peter Greenleaf |
Contact Details
Address: #140, 14315 – 118 Avenue Edmonton, AB T5L 4S6 Canada | |
| Phone | 250 744 2487 |
| Website | auriniapharma.com |
Stock Details
| Ticker Symbol | AUPH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001600620 |
| CUSIP Number | 05156V102 |
| ISIN Number | CA05156V1022 |
| Employer ID | 98-1231763 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Peter S. Greenleaf M.B.A. | President, Chief Executive Officer and Director |
| Joseph M. Miller CPA | Chief Financial Officer |
| Matthew Maxwell Donley M.B.A. | Chief Operations Officer |
| Stephen P. Robertson | Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer |
| Dr. Gregory F. Keenan M.D. | Senior Vice President and Chief Medical Officer |
| Michael Gammons | Vice President and Chief Information Officer |
| Andrea Levin Christopher | Executive Director of Corporate Communications and Investor Relations |
| Richard Lewis | Vice President of Sales |
| Eric Victory | Vice President of Corporate Development |
| Lucy Shieh | Vice President of Human Resources and Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 3, 2026 | SCHEDULE 13D/A | Filing |
| Feb 26, 2026 | 10-K | Annual Report |
| Feb 26, 2026 | 8-K | Current Report |
| Nov 4, 2025 | 8-K | Current Report |
| Nov 4, 2025 | 10-Q | Quarterly Report |
| Aug 13, 2025 | SCHEDULE 13D/A | Filing |
| Jul 31, 2025 | 10-Q | Quarterly Report |
| Jul 31, 2025 | 8-K | Current Report |
| Jun 30, 2025 | 8-K | Current Report |
| May 16, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |